Often referred to as “tranq,” “tranq dope,” or the “zombie drug,” xylazine is frequently combined with fentanyl to enhance its effects. This combination has led to severe health crises in major U.S. cities, including San Francisco, New York, Philadelphia, and Los Angeles.
Public health officials warn Zombie drug is spreading across the U.S.
UA study published in the Journal of Addiction Medicine focused on records from 23 users at the Prevencasa free clinic in Tijuana, Mexico.
The findings were alarming: 82.6% of participant urine samples tested positive for xylazine using Wisebatch test strips, while SAFELife test strips detected the drug in 65.2% of samples.
Notably, all samples also tested positive for fentanyl, underscoring the prevalent co-usage of these substances.
According to The Sun, the deadly zombie drug is becoming more prevalent in Europe and the UK.
Health Risks Associated with Xylazine
Xylazine acts on the central nervous system as a depressant and pain reliever. Its use in humans is associated with profound sedation, complex withdrawal syndromes, and a heightened risk of skin infections and wounds.
